Brittany Bradrick - Jan 12, 2022 Form 3 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role: Director
Signature: /s/ Gerald T. Proehl, Attorney-in Fact
Stock symbol: DRMA
Transactions as of: Jan 12, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/14/2022, 04:07 PM
Next filing: Apr 8, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24. Power of Attorney